Verrica Pharmaceuticals's market cap is currently $67.19M. The company's EPS TTM is $-1.826; its P/E ratio is ―; Verrica Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 5.12M	$ 9.03M	$ 12.00M	$ 0.00	$ 0.00
Gross Profit	$ 4.38M	$ 8.31M	$ 11.53M	$ -229.00K	$ -257.20K
Operating Income	$ -65.76M	$ -21.30M	$ -30.91M	$ -40.18M	$ -30.08M
EBITDA	$ -62.20M	$ -21.60M	$ -30.31M	$ -39.43M	$ -30.08M
Net Income	$ -67.00M	$ -27.68M	$ -38.90M	$ -45.50M	$ -27.95M
Balance Sheet
Cash & Short-Term Investments	$ 69.55M	$ 34.27M	$ 70.35M	$ 65.47M	$ 62.02M
Total Assets	$ 81.60M	$ 44.72M	$ 80.13M	$ 74.15M	$ 68.42M
Total Debt	$ 45.51M	$ 1.53M	$ 43.41M	$ 35.31M	$ 188.00K
Net Debt	$ -24.04M	$ -32.75M	$ 27.66M	$ 24.63M	$ -9.05M
Total Liabilities	$ 61.83M	$ 4.69M	$ 47.52M	$ 41.17M	$ 3.41M
Stockholders' Equity	$ 19.76M	$ 40.03M	$ 32.60M	$ 32.99M	$ 65.02M
Cash Flow
Free Cash Flow	$ -38.94M	$ -18.95M	$ -28.46M	$ -31.68M	$ -28.09M
Operating Cash Flow	$ -38.58M	$ -18.65M	$ -27.58M	$ -30.21M	$ -27.41M
Investing Cash Flow	$ -362.00K	$ 54.04M	$ -998.00K	$ -3.58M	$ 25.95M
Financing Cash Flow	$ 74.21M	$ -16.87M	$ 33.65M	$ 35.23M	$ 423.00K

Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History

Income Statement >

Verrica Pharmaceuticals Debt to Assets

Balance Sheet >

Verrica Pharmaceuticals Cash Flow

Cash Flow >

Verrica Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing